US Physical Therapy Inc

US Physical Therapy Inc(USPH)股票分析

$85.710

-0.266 (-0.31%)收盤時

Loading chart…
最高
86.660
開盤
86.370
成交量加權均價
85.76
成交量
245.99K
市值
1.40B
最低
84.900
成交金額
21.10M
企業價值/稅息折舊攤銷前利潤(TTM)
13.27

U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 795 outpatient physical therapy clinics in 45 states. Its reportable segments include the Physical Therapy Operations segment and the Industrial Injury Prevention Services (IIP) segment. The Physical Therapy Operations segment consists of physical therapy, speech therapy and occupational therapy clinics and home-care physical and speech therapy practices that provide pre- and post-operative care and treatment for a variety of orthopedic-related disorders, sports-related injuries, and rehabilitation of injured workers. The IIP segment includes onsite services for clients’ employees, including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers.

AI 分析 of US Physical Therapy Inc (USPH)

買進

US Physical Therapy Inc is a good buy right now due to its current price of $85.71, which is below the analyst price target range of $90 to $98, indicating potential upside. Additionally, the company has shown a revenue growth of 8.5% year-over-year in Q2 2026, reaching $214.06 million, despite a recent earnings miss. The RSI is at 61.36, suggesting that the stock is in a healthy momentum range, and the forward P/E ratio of 27.25 indicates reasonable valuation compared to growth prospects. However, a key risk is the recent earnings miss, with EPS reported at $0.25, missing expectations by $0.53, which could impact investor sentiment.

分析師評級(7)

上檔空間 +18.42%
持有
2 買進
5 持有
0 賣出
目前: 85.71
最低
100.00
平均
101.50
最高
103.00

JPMorgan

2026-09-11

目標價

$95

增持

Barrington

2026-08-10

目標價

$98

優於大盤

Barrington

2026-05-13

目標價

$90

優於大盤

Citizens

2026-05-08

目標價

$98

優於大盤

Jefferies

2026-03-09

目標價

$102

買進

估值指標

US Physical Therapy Inc(USPH)目前預期本益比為 27.25,5 年平均預期本益比為 32.91。

預期本益比

低估
5 年均值 P/E
32.91
目前P/E
27.25
高估
38.11
低估
27.72

預期 EV/EBITDA

低估
5 年均值 EV/EBITDA
19.09
目前EV/EBITDA
13.27
高估
22.50
低估
15.69

預期股價營收比

低估
5 年均值 P/S
1.94
目前P/S
1.41
高估
2.39
低估
1.49

Alphio AI 對 USPH 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%USPH

$100.54

情境價格

基

基準

基準 · 50%USPH

$97.38

情境價格

悲

悲觀

悲觀 · 25%USPH

$95.30

情境價格

持有 USPH 的大戶

C

Copeland Capital Management, LLC

+ 持有USPH

-7.87%

3個月報酬率

事件時間軸

2026-09-21 (ET)

08:00:00

U.S. Physical Therapy Appoints Myra Davis to Board of Directors

2026-08-05 (ET)

16:30:00

USPH Reports Q2 Revenue of $214.1M, Beating Expectations

16:30:00

U.S. Physical Therapy Confirms FY26 Adjusted EBITDA Outlook of $102M-$106M

2026-07-02 (ET)

08:00:00

U.S. Physical Therapy Acquires 12-Clinic Practice, Holds 67% Stake

2026-05-06 (ET)

16:30:00

USPH Reaffirms 2026 EBITDA Guidance of $102M to $106M

資訊

USPH 常見問題 —— 由 Alphio AI 解答

U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 795 outpatient physical therapy clinics in 45 states. Its reportable segments include the Physical Therapy Operations segment and the Industrial Injury Prevention Services (IIP) segment. The Physical Therapy Operations segment consists of physical therapy, speech therapy and occupational therapy clinics and home-care physical and speech therapy practices that provide pre- and post-operative care and treatment for a variety of orthopedic-related disorders, sports-related injuries, and rehabilitation of injured workers. The IIP segment includes onsite services for clients’ employees, including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

US Physical Therapy Inc is a good buy right now due to its current price of $85.71, which is below the analyst price target range of $90 to $98, indicating potential upside. Additionally, the company has shown a revenue growth of 8.5% year-over-year in Q2 2026, reaching $214.06 million, despite a recent earnings miss. The RSI is at 61.36, suggesting that the stock is in a healthy momentum range, and the forward P/E ratio of 27.25 indicates reasonable valuation compared to growth prospects. However, a key risk is the recent earnings miss, with EPS reported at $0.25, missing expectations by $0.53, which could impact investor sentiment.

7 analysts cover USPH: 2 rate it Buy, 5 Hold and 0 Sell. The average price target is 101.50.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易